![The Lancet Gastroenterology & Hepatology in conversation with artwork](https://is4-ssl.mzstatic.com/image/thumb/Podcasts115/v4/bd/90/74/bd907461-84c1-edd1-5ff2-da3f890b4b3b/mza_50384648226739081.jpg/100x100bb.jpg)
Filip Knop on liraglutide for bile acid diarrhoea
The Lancet Gastroenterology & Hepatology in conversation with
English - September 07, 2022 22:00 - 15 minutes - 10.4 MBLife Sciences Science Education gut intestines ibs ibd bowel medicine research Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Filip Knop (University of Copenhagen) discusses a trial of liraglutide versus colesevelam for the treatment of bile acid diarrhoea.
Read the full article:
Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv